Religare Enterprises' Subsidiary Care Health Insurance Gets Tax Liability Reduced to Rs. 45.16 Crore via Rectification Order

2 min read     Updated on 08 May 2026, 04:19 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Religare Enterprises disclosed that its material subsidiary, Care Health Insurance Limited (CHIL), received a Rectification Order dated April 28, 2026, under Section 154 of the Income Tax Act, 1961, from the Office of the Deputy Commissioner of Income-Tax, Central Circle 6(2) Mumbai. The order corrects a technical error in tax computation for Assessment Year 2023-24, reducing CHIL's net tax liability from Rs. 89.02 Crore to Rs. 45.16 Crore, with no penalty or restriction imposed. An appeal against the original assessment order remains pending, and CHIL's financials are consolidated with Religare Enterprises Limited.

powered bylight_fuzz_icon
39728890

*this image is generated using AI for illustrative purposes only.

Religare Enterprises Limited has disclosed that its material subsidiary, Care Health Insurance Limited (CHIL), has received a Rectification Order dated April 28, 2026, under Section 154 of the Income Tax Act, 1961. The order, issued by the Office of the Deputy Commissioner of Income-Tax, Central Circle 6(2) Mumbai, corrects a technical error in the tax computation pertaining to Assessment Year 2023-24. CHIL received the communication from the authority on May 04, 2026, and the disclosure was made to stock exchanges on May 07, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Tax Liability Significantly Reduced

The rectification order marks a meaningful reduction in CHIL's tax liability following the correction of a computational error identified in the previous demand order. The authority upheld CHIL's rectification application and corrected the technical error in computation, consequently rectifying the original demand. The key financial impact of the rectification is summarised below:

Parameter: Details
Assessment Year: 2023-24
Previous Net Tax Liability: Rs. 89.02 Crore
Revised Net Tax Liability: Rs. 45.16 Crore
Type of Order: Rectification Order under Section 154, Income Tax Act, 1961
Date of Order: April 28, 2026
Date of Receipt by CHIL: May 04, 2026
Issuing Authority: Office of the Deputy Commissioner of Income-Tax, Central Circle 6(2) Mumbai
Penalty/Restriction Imposed: Nil

Background and Regulatory Context

This development is a continuation of Religare Enterprises' earlier disclosure dated March 18, 2026, which pertained to the initial tax demand raised against CHIL for Assessment Year 2023-24. Following that demand, CHIL filed an application for rectification of the mistake apparent from records. Upon verification, the income tax authority accepted CHIL's application and issued the rectification order, reducing the net tax liability from Rs. 89.02 Crore to Rs. 45.16 Crore.

It is important to note that no violation or contravention has been alleged in connection with this order, as the rectification solely addresses a technical error in tax computation. No penalty, restriction, or sanction has been imposed pursuant to this communication.

Appeal Pending; Financials Consolidated with REL

While the rectification order reduces the immediate tax liability, CHIL had previously filed an appeal against the additions made in the original assessment order for Assessment Year 2023-24 with the appropriate authority within the stipulated timelines. The appeal remains pending for adjudication and disposal, and CHIL continues to defend its interest in the matter.

The income tax demand, if required to be paid, is payable by CHIL. The financials of CHIL are consolidated with Religare Enterprises Limited. The disclosure was signed by Anuj Jain, Company Secretary & Compliance Officer of Religare Enterprises Limited.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.61%-0.21%-13.67%+5.29%+122.89%

How might the outcome of CHIL's pending appeal against the original assessment order further impact Religare Enterprises' consolidated financials beyond the current rectified liability of Rs. 45.16 Crore?

Could this tax rectification signal broader scrutiny of health insurance companies' tax computations by Indian income tax authorities, and how might peers like Star Health or Niva Bupa be affected?

What provisions, if any, has Religare Enterprises already made in its consolidated balance sheet for CHIL's tax liability, and will the reduction necessitate a reversal of excess provisions in upcoming quarterly results?

Religare Enterprises Schedules Board Meeting & Earnings Call for Q4 & FY26 Results

2 min read     Updated on 08 May 2026, 03:45 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Religare Enterprises has announced a Board of Directors meeting on May 12, 2026, to approve Standalone and Consolidated Audited Financial Results for Q4 and FY26, followed by an earnings call on May 13, 2026, at 4:00 PM IST for management to discuss operational and financial performance. The trading window, closed since April 01, 2026, will reopen on May 14, 2026, 48 hours after the results declaration.

powered bylight_fuzz_icon
39722817

*this image is generated using AI for illustrative purposes only.

Religare Enterprises has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Tuesday, May 12, 2026, to consider and approve its audited financial results. Additionally, the company's management has scheduled an earnings call on Wednesday, May 13, 2026, to discuss the operational and financial performance for Q4 and FY26. Both intimations have been filed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The Board meeting has been convened to consider and approve the Standalone and Consolidated Audited Financial Results of the company for the Quarter and Financial Year ended March 31, 2026. The key details of the scheduled meeting are outlined below:

Parameter: Details
Meeting Date: Tuesday, May 12, 2026
Purpose: Approval of Standalone and Consolidated Audited Financial Results
Period Under Review: Quarter and Financial Year ended March 31, 2026
Regulatory Basis: Regulation 29 of SEBI (LODR) Regulations, 2015

Earnings Call Details

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the management of Religare Enterprises and its subsidiaries has scheduled an earnings call to discuss the operational and financial performance for Q4 & FY26. The details of the earnings call are as follows:

Parameter: Details
Day/Date: Wednesday, May 13, 2026
Time: 04:00 PM IST
Primary Numbers: +91 22 6280 1102 / +91 22 7115 8003
Toll Free – USA: 1 866 746 2133
Toll Free – UK: 0 808 101 1573
Toll Free – Singapore: 800 101 2045
Toll Free – Hong Kong: 800 964 448
RSVP Contact: teamreligare@adfactorspr.com

Participants are requested to pre-register for the call via the provided link. The call will be attended by the Management Team of Religare Enterprises and its subsidiaries.

Trading Window Closure

In continuation of an earlier announcement dated March 27, 2026, Religare Enterprises also informed the exchanges regarding the Trading Window Closure period applicable to dealings in the company's shares. The relevant details are as follows:

Parameter: Details
Trading Window Closure Start: April 01, 2026
Trading Window Reopens: 48 hours after declaration of financial results
Effective Reopening Date: May 14, 2026

The Trading Window was closed from April 01, 2026, and shall remain closed until 48 hours after the declaration of the aforementioned financial results, which translates to May 14, 2026. This closure is in compliance with applicable SEBI regulations governing insider trading restrictions during periods preceding the announcement of financial results.

Both intimations were signed by Anuj Jain, Company Secretary & Compliance Officer of Religare Enterprises, and were filed on May 07, 2026.

Historical Stock Returns for Religare Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
-0.23%+0.61%-0.21%-13.67%+5.29%+122.89%

How might Religare Enterprises' FY26 financial results reflect the impact of ongoing ownership disputes and corporate governance challenges on its core businesses like Care Health Insurance and Religare Broking?

Will the Q4 FY26 earnings call provide any clarity on Religare Enterprises' strategic roadmap following the prolonged battle for control between the Burman family and other stakeholders?

Could strong or weak FY26 results trigger renewed merger and acquisition interest or open market activity in Religare Enterprises shares once the trading window reopens on May 14, 2026?

More News on Religare Enterprises

1 Year Returns:+5.29%